In response to the rapid advancements in artificial intelligence (AI) and the evolving landscape of patent law, the United States Patent and Trademark Office (USPTO) has issued a comprehensive guidance
Continue Reading USPTO Issues New Guidance on Patent Subject Matter Eligibility for AI Inventions
On April 11, 2024, the U.S. Patent and Trademark Office issued Guidance on Use of Artificial Intelligence-Based Tools in Practice Before the U.S. Patent and Trademark Office (April Guidance). The
Continue Reading Key Takeaways From the Latest USPTO Guidance on AI
Patents buttress and backstop growth for medical technology (medtech) companies, period. This is especially so for early-stage ventures staking their claim in the medtech ecosystem. A strategic patent portfolio is
Continue Reading Mind the gap: Strengthen your patent portfolio with a white space analysis
This 5 Trends piece covers specialized offerings, autonomous vehicle companies, the drone industry, robotic-assisted surgeries, and intellectual property in robotics industry.
Continue Reading 5 Trends to Watch: 2024 Robotics
David J. Dykeman, co-managing shareholder of global law firm Greenberg Traurig, LLP’s Boston office and co-chair of the firm’s global Life Sciences & Medical Technology Group, was featured
Continue Reading David Dykeman Featured on Product Success Podcast: Quality and Medical Devices
Greenberg Traurig, LLP Shareholder Andrew B. Schwaab will present the Silicon Valley Intellectual Property Law Association’s (SVIPLA) annual 2020 Inventor of the Year award to prolific inventor and technologist,
Continue Reading Greenberg Traurig Congratulates Robert Cousins, Named 2020 Inventor of the Year
From floating infrastructure to biohacking, floating solar farms to AgTech, projects that are first of their kind bring with them exciting opportunities, but also unique legal complexities. In this recent
Continue Reading Maneuvering ‘Unicorns’ – Opportunities and Risks of Unprecedented Projects
The search for a vaccine for the COVID-19 strain of coronavirus has put the spotlight once again on the innovative pharmaceuticals sector. As pharmaceutical companies and innovators across the globe work diligently on a vaccine, many of these companies may be looking to protect their innovation. While patents have many benefits, in the face of a global health emergency, there are some key factors innovators should consider.
Timeline for Patent Registration
Patents can provide broad protection for invention and innovation. They can also create a significant advantage in the marketplace. However, patent registration takes time and may require significant resources. According to the United States Patent and Trademark Office (USPTO), on average, it takes approximately 22 months to get patent approval. This period may be shortened by taking advantage of one of the USPTO’s accelerated examination procedures and may be shortened by utilizing the USPTO prioritized examination option, where a final decision on patentability is made within 12 months from the filing date of the patent application.
Continue Reading The Race for a COVID-19 Vaccine is On: Key Factors May Impact Patent Protection
On April 28, 2020, the United States Patent and Trademark Office (USPTO) announced a new extension of certain submissions and fees under the Coronavirus Aid, Relief, and Economic Security Act
Continue Reading USPTO Announces Extensions Under CARES Act